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The dynamics and route of T. gondii endocytic trafficking are undefined. We show host proteins are endocytosed across the parasitophorous vacuole 
membrane (PVM) within 7 minutes post-invasion, trafficked in a TgDrpB-independent manner through endosome-like compartments, and are delivered 
to the parasite’s lysosome-like compartment (VAC) for degradation within 30 minutes. Endocytic trafficking occurs simultaneously with exocytic 
trafficking to the parasite’s regulated secretory organelles, micronemes (Mn) and rhoptries (Rh), but intersects with microneme trafficking only.  
endosome-like compartments; ELC. 
 
 
 
 
 
 
 
ABSTRACT 
Host cytosolic proteins are endocytosed by Toxoplasma gondii and degraded in its lysosome-like compartment, the VAC, but the 
dynamics and route of endocytic trafficking remain undefined. Conserved endocytic components and plant-like features suggest T. 
gondii endocytic trafficking involves transit through early and late endosome-like compartments (ELCs) and potentially the trans-Golgi 
network (TGN) as in plants. However, exocytic trafficking to regulated secretory organelles, micronemes and rhoptries, also proceeds 
through ELCs and requires classical endocytic components including a dynamin-related protein, DrpB. Here we show that host 
cytosolic proteins are endocytosed within 7 min post-invasion, trafficked through ELCs en route to the VAC, and degraded within 30 
min. We could not definitively interpret if ingested protein is trafficked through the TGN. We also found that parasites ingest material 
from the host cytosol throughout the parasite cell cycle. Ingested host proteins colocalize with immature microneme proteins, proM2AP 
and proMIC5, in transit to the micronemes, but not with the immature rhoptry protein proRON4, indicating that endocytic trafficking of 
ingested protein intersects with exocytic trafficking of microneme proteins. Finally, we show that conditional expression of a DrpB 
dominant negative mutant increases T. gondii ingestion of host-derived proteins, suggesting that DrpB is not required for parasite 
endocytosis. 
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INTRODUCTION 
Toxoplasma gondii is a eukaryotic, obligate intracellular parasite 
that resides within a membrane compartment called the 
parasitophorous vacuole (PV). T. gondii belongs to the phylum 
Apicomplexa, which also includes other notable human 
pathogens such as Plasmodium, the causative agents of human 
malaria. While T. gondii infection of immunocompetent 
individuals usually results in mild flu-like symptoms, reactivated 
chronic infection in immunocompromised individuals or 
congenital infection through vertical transmission can be life 
threatening, produce symptoms similar to septic shock and 
potentially leading to vision loss.1, 2 Toxoplasmosis is believed to 
be lifelong and is currently incurable, leaving the two billion 
people chronically infected worldwide susceptible to the 
consequences of reactivated toxoplasmosis.1, 2 Therefore, a 
better understanding of the fundamental features of infection is 
needed to uncover new treatment options and limit the burden of 
toxoplasmosis.  
     One of the most central and necessary aspects of life for a 
eukaryotic cell is endocytosis. Endocytosis is pathway by which 
material is taken up across the plasma membrane and trafficked 
to the lysosome for digestion. An analogous pathway was 
recently discovered in T. gondii termed the ingestion pathway. In 
T. gondii ingestion, proteins acquired from the host cell cytosol 
are trafficked across the PV and parasite plasma membrane to a 
lysosome-like compartment within the parasite termed the 
vacuolar compartment/plant-like vacuole (VAC/PLV; the term 
VAC will be used hereafter) for degradation.3 The ability to 
deliver host cytosol and/or parasite-derived material to the VAC 
for digestion contributes to the acute stage infection and is 
especially important for chronic infection.3, 4 However, how 
ingested cargoes are delivered to the VAC is not known. 
     Endocytic trafficking to the lysosome is highly conserved 
among eukaryotes with a slight variation observed in plants. In 
mammalian and yeast cells, endocytic cargoes are delivered 
sequentially to the Rab5 compartment, the Rab7 compartment 
and finally to the lysosome.5 Plant cells, on the other hand, 
initially deliver endocytosed cargoes to the trans-Golgi network 
(TGN), followed by sequential movement through the Rab5 
compartment, the Rab7 compartment and finally the lysosome 
for degradation.6 Toxoplasma has a conserved endomembrane 
structure including a TGN, endosome-like compartments (ELCs) 
marked by Rab5 and Rab7, and the lysosome-like VAC, and 
also expresses the essential machinery for endocytic trafficking 
to lysosomes including clathrin, dynamin, Rab5 and Rab7.7 The 
presence of a plant-like lysosome and a plant-specific proton 
pump (TgVP1) within the T. gondii endolysosomal system8 
suggests that endocytic trafficking in T. gondii may resemble 
plants as proposed by Pieperhoff et al.9 However, exocytic 
trafficking of proteins destined for the parasite’s regulated 
secretory organelles, the micronemes and rhoptries, proceeds 
through the TGN and ELCs, and requires clathrin, dynamin and 
Rab5 for transit.9-16 In contrast to the ingestion pathway, which 
leads to the destruction of its cargo, most microneme and rhoptry 
proteins have propeptides that are cleaved off during transit to 
the microneme and rhoptry organelles, but must otherwise 
remain intact to orchestrate parasite invasion, egress and 
defense against host immune attack.17-27 Without these exocytic 
proteins and organelles, the parasite cannot  establish a 
successful infection. 
     How T. gondii ensures proper targeting of endocytic and 
exocytic cargo is unclear, but other eukaryotic systems reveal 
several possible mechanisms. Endocytic and exocytic trafficking 
may be spatially regulated like certain GPI-anchored proteins 
that traffic directly to the plasma membrane from the TGN, 
avoiding endosomes in mammalian cells.28 Alternatively, these 
processes may be temporally regulated. In Plasmodium spp., 
endocytosis of red blood cell cytoplasm is most active in G1 and 
early S phase, whereas microneme organelle biogenesis occurs 
later in the late S and mitosis and cytokinesis (M/C) phases.29-33 
Another scenario is that endocytic and exocytic trafficking 
intersect and require sorting mechanisms to ensure proper 
targeting. This is illustrated by the TGN in plants, which serves 
as a sorting station for endocytic and exocytic cargoes, or by 
transferrin receptors in mammalian cells, which traffic through 
endosomes before reaching the plasma membrane.28, 34 
     In this study, we determined temporal and spatial 
relationships between endocytic and exocytic trafficking within T. 
gondii and investigated the role of the dynamin-related protein 
DrpB in endocytic trafficking. We find that host cytosolic proteins 
are ingested during or immediately following invasion, are 
trafficked through ELCs, and delivered to the VAC for 
degradation in 30 min. Ingestion and immature promicroneme 
proteins can be detected in all phases of the cell cycle, whereas 
immature prorhoptry protein detection is restricted to the S and 
M/C phases. Further, ingested proteins colocalize with 
promicroneme, but not prorhoptry proteins, suggesting endocytic 
trafficking of ingested protein intersects with exocytic trafficking 
of microneme proteins. Finally, endocytic trafficking of ingested 
protein does not require DrpB, but may require a DrpB binding 
partner. 
 
RESULTS 
Localization of TGN/ELC markers: GalNac and DrpB 
Plant-like features of T. gondii led to the prediction that ingested 
proteins follow a plant-like endocytic route through the TGN and 
ELCs en route to the VAC. To test if the endocytic trafficking is 
plant-like in T. gondii, we generated a parasite line stably 
expressing UDP-GalNAc:polypetide N-acetylgalactosaminyl-
transferase fused to YFP (GalNac-YFP), typically used as a TGN 
marker. 35 Consistent with TGN localization, GalNac-YFP 
appeared in a centrally located structure that overlapped 
substantially with, or was just apical to, the Golgi marker 
GRASP55-mRFP (Figure S1). As previously observed, GalNac-
YFP sometimes showed a high degree of overlap with another 
TGN marker the dynamin-related protein DrpB (Figure S1A top 
panel), but in other cases showed partial or no overlap with DrpB 
(Figure S1A bottom panel). Interestingly, GalNac-YFP 
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overlapped best with NHE3 in the central region of the parasite 
despite previous observations that NHE3 partially colocalized 
with the VAC.36 Therefore, we interpret NHE3 to be an ELC 
marker that partially overlaps with the TGN, similar to the 
established ELC marker proM2AP.10, 37 GalNac-YFP also 
partially overlapped with proM2AP, but rarely colocalized with 
the VAC markers CPB and CPL or the apicoplast. We also 
observed that some parasites had GalNac-YFP-labeled 
structures that were not associated with GRASP55-mRFP 
(Figure S1, white arrowheads). These structures are reminiscent 
of “Golgi-free” TGN bodies in plants38 This observation together 
with substantial overlap with the ELC marker proM2AP, suggests 
GalNac-YFP occupies the TGN, ELCs, and perhaps additional 
sites. 
     To visualize DrpB as a second marker of the TGN we utilized 
the RH∆hx ddFKBP-GFP-DrpB WT (ddGFP-DrpB WT) strain.12 
These parasites express an ectopic copy of DrpB fused to GFP 
and a destabilization domain (dd), which allows for post-
translational control of protein expression upon adding the 
stabilizing drug Shield-1. To minimize possible off-target effects 
due to DrpB overexpression, Shield-1 treatment was optimized 
to observe ddGFP-DrpB WT expression in the majority of 
parasites with minimal treatment: 0.8µM Shield-1 for 30 min. 
Under these conditions, ddGFP-DrpB WT overexpression did not 
interfere with microneme trafficking as previously observed 
(Figure S2A and B).12 As shown in Figure S1, DrpB localization 
was slightly different from that of GalNac-YFP. ddGFP-DrpB WT 
showed little to no overlap with the VAC marker CPL, but 
colocalized most prominently with proM2AP and only partially 
overlapped with NHE3 (Figure S2C top panels). This localization 
was confirmed by staining of endogenous DrpB with a DrpB 
antibody, suggesting overexpression under these conditions also 
did not cause mislocalization of ddGFP-DrpB WT (Figure S2C 
bottom panels).  Taken together, these findings suggest that 
ddGFP-DrpB WT may also localize to both the TGN and ELCs. 
 
Ingested proteins traverse ELCs 
The ability of T. gondii to ingest proteins from the host cytosol 
can be monitored using fluorescent protein reporters such as 
mCherry (Figure 1A). Chinese hamster ovary (CHO-K1) cells 
transiently transfected with a plasmid encoding cytosolic 
mCherry are infected with T. gondii and incubated to allow 
consumption of host cytosol. Parasites are then purified from 
host cells and analyzed by fluorescence microscopy. In our 
previous study, accumulation of ingested host protein was 
enhanced by the absence of the VAC-localized protease CPL or 
by treatment with a CPL inhibitor, morpholinurea-leucine-
homophenylalanine-vinyl phenyl sulfone (LHVS).3 mCherry+ 
parasites are capable of invading new host cells, indicating that 
these parasites are viable (Figure S3A-C). When LHVS-
dependent accumulation of ingested host protein ingestion is 
detected, the ingestion pathway is considered to be active, and 
the percentage of ingested mCherry puncta overlapping with 
endolysosomal system markers (%Colocalized) can be 
determined as a measure of localiztion.  
     To determine which endolysosomal compartments ingested 
protein traffics through on the way to the VAC, GalNac-YFP, WT 
(RH), or ddGFP-DrpB WT parasites were treated and processed 
as shown in Figure 1A with the addition of Shield-1 treatment to 
induce stabilization of ddGFP-DrpB WT, and stained with 
antibodies against proM2AP, NHE3, or CPB. As a negative 
control, the apicoplast, a compartment that is in the same region 
as, but distinct from, the endolysosomal system, was stained 
with DAPI as a test for random colocalization. Ingestion was 
found to be active in all three strains, and Shield-1 treatment of 
ddGFP-DrpB WT parasites did not affect ingestion (Figure 1B-
D). Localization analysis in these parasites revealed that 
ingested protein significantly colocalized with GalNac-YFP, 
ddGFP-DrpB WT, proM2AP and CPB, but not NHE3 when 
compared to the apicoplast (Figure 1E and F).  
     Similar levels of colocalization of ingested protein with 
ddGFP-DrpB WT and proM2AP are expected due to their high 
degree of overlap (Figure S2C), but why ingested protein 
colocalized significantly with GalNac-YFP, but not NHE3 despite 
their near perfect overlap in the central region of the parasite 
was puzzling. Further investigation revealed that most of the 
ingested mCherry that colocalized with GalNac-YFP also 
simultaneously colocalized with CPB (Figure S3D and E). This 
was not due to redistribution of GalNac-YFP in response to 
LHVS treatment since overlap of GalNac-YFP with CPB and 
CPL did not change with treatment (Figure S3F). GalNac-YFP 
also still showed substantial overlap with NHE3 in the central 
region of the parasite, and both GalNac-YFP and NHE3 showed 
only rare overlap with CPB when treated with LHVS (Figure 
S3G). Further analysis of the GalNac-YFP+CPB+ compartment 
showed that it is labeled with CPL, proM2AP and NHE3 (Figure 
S3H), implying it is a subdomain of the ELCs or the VAC rather 
than the TGN.  However, we cannot rule out the possibility that 
GalNac+CPB+ puncta represent a TGN subcompartment 
reserved for sorting of both ingested and biosynthetic cargoes to 
the ELCs and VAC. Although we can clearly distinguish 
localization of ingested protein from the apicoplast and NHE3 
compartment, the dynamic localization of TGN markers within 
the apical region of the parasite makes their colocalization with 
ingested protein difficult to definitively interpret. Therefore, we 
cannot conclusively determine whether ingested proteins are 
trafficked through the TGN. Nevertheless, the data is consistent 
with ingested proteins trafficking through ELCs on the way to the 
VAC.  
 
Ingested proteins reach the VAC for CPL-dependent 
digestion within 30 min 
To better understand the dynamics of ingested protein trafficking 
to the VAC, GalNac-YFP parasites were treated as shown in 
Figure 1A, purified at 15 min intervals through the first hour of 
infection, and LHVS-treated parasites were stained with 
antibodies against CPB and CPL to label the VAC. Parasite-
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associated mCherry was detected at the earliest time point (7 
min post-invasion) and throughout the first hour of infection 
(Figure 2A). Intriguingly, accumulation of mCherry at 7 min post-
invasion was independent of LHVS treatment (Figure 2A). 
Although external protease treatment of purified parasites is 
routinely performed to remove host protein sticking to the 
parasite surface, we wanted to ensure the mCherry 
accumulation was truly inside the parasite. Deconvolution of Z-
stack images confirmed that the mCherry accumulation is fully 
contained within the parasite, and ingested mCherry was 
resistant to external protease treatment while the parasite 
surface protein SAG1 was not (Figure S4A and B). These 
findings suggest host proteins are ingested either during or 
immediately after invasion and initially delivered into a non-
proteolytic compartment. 
     Detection of ingested mCherry became increasingly 
dependent on LHVS treatment at 22 min post-invasion and 
beyond with ingestion in DMSO-treated parasites reaching the 
typically observed basal levels by 37 min post-invasion (Figure 
2A). Colocalization of ingested mCherry with CPB/L increases as 
detection of ingested protein in DMSO-treated parasites 
decreases, and colocalization with CPB/L peaks at 37 min post-
invasion (Figure 2B and C). This suggests that ingested host 
proteins are trafficked to the VAC and degraded within 30 min. 
Localization within the GalNac-YFP+CPB/L+ compartment also 
peaked at 37 min post-invasion (Figure S4C), indicating that this 
compartment is digestive in nature, further supporting its identity 
as a subdomain of the ELCs or the VAC. 
 
Promicroneme proteins are detected in all cell cycle phases 
Antibody staining against propeptides of microneme and rhoptry 
proteins label newly synthesized, immature promicroneme and 
prorhoptry proteins in transit to their respective organelles and 
possibly also cleaved propeptide, but not mature proteins in the 
microneme and rhoptry organelles. For example, staining for the 
propeptide of the microneme protein M2AP (proM2AP) or rhoptry 
protein ROP4 (proROP4) shows overlap with the TGN and ELCs 
but not the micronemes or rhoptries.10, 16, 37, 39 Therefore, the 
colocalization of ingested protein with proM2AP noted above 
suggests that endocytic trafficking to the VAC may intersect with 
exocytic trafficking to microneme and rhoptry organelles. An 
important limitation of this experiment, however, is that parasites 
were treated with LHVS for 36 h prior to infection to emulate 
detection of ingested host protein in the CPL knockout. Under 
these conditions, ingested host protein persists with a half-life of 
2 to 3 h.3 Persistent accumulation presumably occurs within the 
VAC, but trafficking might also be backed up in upstream 
compartments like the ELCs. Therefore, we cannot differentiate 
protein ingested several hours ago from actively trafficking, 
newly ingested protein. So while we conclude that proM2AP and 
ingested protein are trafficked through the ELCs, this experiment 
does not conclusively demonstrate that they occupy the ELCs at 
the same time under normal conditions. Nevertheless, how these 
cargoes can be trafficked through the same compartment, yet 
meet very different fates is unclear.  
     To test if endocytic and exocytic trafficking in T. gondii are 
temporally separated processes, we next sought to determine 
when during the cell cycle microneme or rhoptry biogenesis and 
ingestion occur. T. gondii divides by building daughter parasites 
within the mother cell in a process called endodyogeny and has 
a cell cycle characterized by three phases: G, S, M/C.40 
Progression through the T. gondii cell cycle can be monitored 
using two markers: TgCentrin2 (Cen2) which associates with the 
centrosome and additional apical structures, and IMC1 which 
associates with the inner membrane complex and outlines the 
periphery of the mother cell and newly forming daughter 
parasites.41 In the G phase, parasites display a single mother 
IMC1 structure and a single centrosome. In S phase, the 
centrosome is duplicated and in M/C phase, two additional U-
shaped IMC1 structures outlining the newly forming daughter 
cells will appear within the IMC1 outline of the mother parasite. 
To test when microneme or rhoptry biogenesis occurs during the 
cell cycle, Cen2-EGFP parasites were stained with antibodies 
against IMC1 to determine cell cycle phase and against 
propeptides of microneme and rhoptry proteins, which in 
previous experiments have been associated with timing of 
microneme and rhoptry biogenesis.21  
     We first examined microneme protein synthesis using 
antibodies against proM2AP and proMIC5. proM2AP staining 
has been observed in all phases of the cell cycle, but to what 
extent remained unclear.10, 37 Parasites were analyzed at 4 to 6 h 
post-invasion when parasites in all three phases of the cell cycle 
were present. proM2AP and proMIC5 were detected in G, S and 
M/C phases, and in the majority of parasite-containing vacuoles  
(Figure 3A-D). To ensure that this was not a product of pulse 
invasion into host cells or only characteristic of the first cell 
division, asynchronous, overnight cultures of parasites allowed to 
naturally invade host cells were also analyzed. Again, proM2AP 
and proMIC5 were detected in G, S and M/C phases and in the 
majority of parasite-containing vacuoles (Figure 3E-H), 
suggesting that microneme protein synthesis occurs throughout 
the cell cycle. 
 
Prorhoptry proteins are detected in S and M/C phases 
We next examined detection of rhoptry protein synthesis using 
antibody staining against proROP4 or proRON4, which is known 
label M/C phase parasites.20, 42 The antibody mAb T5 4H1 used 
to detect proRON4, also detects the moving junction. As 
previously observed, staining of the moving junction remained on 
the PVM at 4 to 6 h post-invasion and could not be distinguished 
from staining within the parasites.21, 42 Therefore, RON4 
synthesis was only analyzed in asynchronous overnight cultures. 
proROP4 and proRON4 were detected in both S and M/C 
phases, but were absent from nearly all parasite vacuoles in G 
phase at 4 to 6 or 24 h post-invasion (Figure 4). This suggests 
that rhoptry protein synthesis is restricted to later in the cell 
cycle, and occurs in both S and M/C phases.  
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Ingestion is active throughout the cell cycle 
We next sought to determine when during the cell cycle T. gondii 
ingests host proteins. To more precisely measure when 
parasites are ingesting protein from the host cell, LHVS 
treatment was reduced from 36 h to 30 min, adding LHVS 
immediately prior to parasite purification (Figure 5A). This is the 
time it takes to complete one ingestion event from uptake to turn 
over (Figure 2) and should reflect only recently ingested protein. 
To do this, the LHVS concentration had to be increased from 1 
µM to 50 µM, but detection of ingested protein under this 
condition was indistinguishable from parasites treated with LHVS 
for 36 h (Figure 5B). 
     To test when during the cell cycle the ingestion pathway is 
active, Cen2-EGFP parasites were treated as in Figure 5A, 
purified at 4 to 6 h post-invasion when all cell cycle phases were 
observed (Figure 5C), and stained with antibodies against IMC1. 
Because promicroneme and prorhoptry proteins were detected 
with similar cell cycle dynamics during the first and subsequent 
cell division cycles (Figure 3 and 4), cell cycle dependence of 
ingestion was not analyzed at 24 h post-invasion for comparison. 
In samples where ingestion was active (Figure 5D), ingestion of 
mCherry was observed in parasites of all three cell cycle phases 
(Figure 5E). To determine if ingestion is down regulated in any 
phase of the cell cycle, the percentage of mCherry positive 
parasites was also determined in G, S or M/C phase parasites. 
No significant differences were observed, suggesting that 
ingestion is equally active during all phases of the cell cycle 
(Figure 5F). 
 
Ingested host protein trafficking intersects with microneme 
protein trafficking 
Although our results indicate that ingestion, microneme protein 
synthesis, and rhoptry protein synthesis are active during the 
same cell cycle phases and traffic through the ELCs, it is still 
possible that ingested proteins and microneme or rhoptry 
proteins could avoid interaction. For example, sequential rounds 
of ingestion and microneme or rhoptry synthesis could occur 
independent of the cell cycle. To determine if ingestion is down-
regulated during microneme or rhoptry synthesis and if their 
trafficking paths intersect as suggested by our findings in Figure 
1, we compared the trafficking of newly ingested protein with that 
of newly synthesized microneme and rhoptry proteins en route to 
their respective apical secretory organelles. 
     To do this, a new cell line developed during the course of this 
study was used. These cells, termed CHO-K1 inducible mCherry 
cells (CHO-K1 imCh), produce cytosolic mCherry in response to 
induction with doxycycline (Figure S5A). mCherry is expressed in 
76.0±0.42% of doxycycline-treated CHO-K1 imCh cells 
compared to 18.6±4.3% of transiently transfected CHO-K1 cells 
(Figure S5B). Consistent with the broader expression, we 
observed mCherry in 42.6±8.7% of parasites treated with LHVS 
for 36 h. Also, ingested mCherry was detected in 16.5±4.1% of 
parasites treated with LHVS for 30 min, although in this case the 
LHVS concentration had to be increased to 200 µM to 
consistently detect LHVS-dependent mCherry accumulation 
(Figure S5C and D). It should be noted that despite broader 
expression the mCherry fluorescence intensity of CHO-K1 imCh 
cells is about 2.8 times lower than transiently transfected CHO-
K1 cells (Figure S5B). Thus, results from CHO-K1 imCh cells 
might still underrepresent the proportion of parasites that are 
actively ingesting host-derived protein. 
     To determine if ingestion is down-regulated during microneme 
or rhoptry biogenesis, parasites were allowed to ingest mCherry 
from doxycycline-treated CHO-K1 imCh cells and treated with 
LHVS for 30 min to exclusively detect newly ingested host 
protein. The parasites were then purified and stained for 
proM2AP, proMIC5 and proRON4 to detect newly synthesized 
microneme and rhoptry proteins. We attempted to detect 
proROP4, but the antibody did not work well in extracellular 
parasites. In samples where ingestion was active (Figure 6A), 
the activity of the ingestion pathway during microneme and 
rhoptry biogenesis was analyzed by determining the percentage 
of mCherry positive parasites in populations expressing proMIC5 
or proRON4 compared to populations of parasites that are 
negative for each of these markers. This analysis was not 
performed for proM2AP since 85.9±8.2% of parasites were 
expressing proM2AP. Ingestion pathway activity was not 
significantly different in proMIC5+ versus proMIC5- or proRON4+ 
versus proRON4- subpopulations, suggesting that ingestion is 
not down-regulated during microneme or rhoptry biogenesis 
(Figure 6B and C). Interestingly, even though ingestion is active 
during microneme and rhoptry biogenesis, ingested protein 
colocalized with proM2AP and proMIC5, but not proRON4 when 
compared to the apicoplast negative control (Figure 6D and E). 
Therefore, endocytic trafficking of ingested host proteins 
intersects with exocytic trafficking to micronemes, but not to 
rhoptries, suggesting that rhoptry trafficking may diverge earlier 
in the endolysosomal system such as the TGN or occupy 
functionally distinct ELCs. 
 
T. gondii ingestion does not require DrpB 
DrpB promotes exocytic trafficking of a subset of microneme and 
rhoptry proteins, but significant colocalization of ingested protein 
with DrpB suggests that DrpB could also be involved in endocytic 
trafficking in T. gondii. Dynamins are GTPases best known for 
their role in fission of endocytic vesicles forming at plasma 
membrane into the cytosol, but can also promote membrane 
fission at the TGN, endosomes and mitochondria43, 44 T. gondii 
DrpB localizes to the TGN and potentially the ELCs, but has not 
been observed at the parasite plasma membrane.9, 12 However, 
given that dynamin-dependent fission of endocytic vesicles at the 
plasma membrane is conserved in plants, mammals, fungi and 
other protozoan parasites including Plasmodium43-47, transient 
populations of DrpB that are difficult to detect by traditional 
microscopy could promote endocytosis at the plasma membrane 
similar to the yeast dynamin-like protein Vps1.46 If this is true, 
then interfering with DrpB function will inhibit ingestion and 
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reduce the percentage of mCherry+ parasites. DrpB could also 
play a role in downstream trafficking of ingested proteins at the 
ELCs. In this case, interfering with DrpB function will interfere 
with delivery of ingested protein to the VAC, reducing 
colocalization of ingested mCherry with VAC markers and 
potentially preventing its degradation. 
     To test whether DrpB plays a role in endocytic trafficking, an 
inducible dominant negative DrpB mutant was expressed to 
interfere with DrpB function using RH∆hx ddFKBP-GFP-DrpB 
K72A (ddGFP-DrpB K72A) parasites. Parasites treated with the 
vehicle control ethanol are essentially wildtype, but addition of 
Shield-1 stabilizes ddGFP-DrpB K72A, a GTPase mutant shown 
to interfere with dynamin function in endocytosis in other 
organisms.48 Prolonged, overnight treatment with Shield-1 in this 
strain leads to aberrant secretion of microneme and rhoptry 
proteins such as MIC3 into the PV lumen, depletion of 
microneme and rhoptry organelles and non-invasive parasites.12 
To avoid issues with invasion for the ingestion assay, Shield-1 
treatment was optimized to induce dominant negative effects in 
short periods of time. A significant percentage of vacuoles were 
positive for MIC3 staining in the PV lumen within 3 but not 2 h of 
1µM Shield-1 treatment when compared to the vehicle ethanol-
treated control (Figure 7 A and B). Therefore, ingestion assays 
were performed with ddGFP-DrpB K72A parasites as in Figure 6 
with 30 min LHVS treatment to observe recently ingested protein 
and Shield-1 treatment for up to 3 h to induce expression of 
ddGFP-DrpB K72A. Following harvest and fixation, parasites 
were stained with antibodies against proM2AP and CPL or DAPI 
to label the apicoplast, and the percentage of mCherry+ 
parasites and localization of ingested mCherry was determined. 
     ddGFP-DrpB K72A parasites treated with LHVS and ethanol 
(vehicle for Shield-1) accumulated mCherry, confirming that 
ingestion is active in this parasite strain (Figure 7C). 
Interestingly, parasites treated with LHVS and Shield-1 showed a 
significant increase in the percentage of mCherry+ parasites 
compared to those treated with LHVS and ethanol (Figure 7C). A 
similar increase was not observed in DMSO-treated ddGFP-
DrpB K72A parasites or in wildtype RH parasites treated with 
Shield-1, suggesting the increased accumulation of ingested 
protein was not due to defects in the turnover of ingested protein 
or off-target effects of Shield-1 itself (Figure 7C and D). Taken 
together, this suggests that DrpB is not required for fission of 
endocytic vesicles at the plasma membrane, but may indirectly 
restrict the rate of ingested protein endocytosis. 
     Normal turnover of ingested mCherry in parasites treated with 
DMSO and Shield-1 also suggested that the mCherry was being 
delivered to the VAC. To confirm this, the localization of ingested 
mCherry was determined. As previously observed, ingested 
mCherry showed significant colocalization with proM2AP and 
CPL when compared to the apicoplast in ethanol-treated control 
samples (Figure 7E). When comparing ethanol and Shield-1-
treated parasites, colocalization of ingested mCherry with 
proM2AP and the apicoplast was not affected, but surprisingly 
colocalization with the VAC marker CPL was significantly 
increased (Figure 7E). Localization of CPL relative to NHE3, 
proM2AP and CPB and the staining pattern of these markers 
was not altered under the same Shield-1 treatment conditions, 
excluding the possibility that increased colocalization with 
ingested mCherry was due to redistribution of CPL into multiple 
endocytic compartments, e.g. the VAC and ELCs (Figure 7F-H). 
Taken together, this suggests that DrpB is also not required for 
downstream endocytic trafficking of ingested protein to the VAC 
or trafficking of CPL. Consistent with this, ddGFP-DrpB K72A 
showed almost no association with the endolysosomal system, 
maintaining reduced but significant localization with proM2AP, 
but not NHE3, and was not significantly associated with ingested 
mCherry or CPL (Figure 7E and G-I). This suggests that ddGFP-
DrpB K72A may indirectly increase colocalization between 
ingested mCherry and CPL, potentially through enhancing the 
rate of endocytic trafficking to the VAC. Proposed mechanisms 
for these observations are discussed below. These results also 
provide functional distinction between exocytic and endocytic 
trafficking in T. gondii, with DrpB likely being devoted to exocytic 
trafficking only. 
 
DISCUSSION 
Trafficking of Ingested Proteins 
Our data are consistent with ingested proteins trafficking through 
the ELCs on the way to the VAC, however we could not 
conclusively determine if ingested protein is trafficked through 
the TGN due to extensive localization of GalNac–YFP and 
ddGFP-DrpB WT with ELC markers. Additionally, ingested 
protein colocalized with GalNac-YFP in a compartment that 
predominantly labeled with CPB and CPL and seems to be 
digestive in nature. This suggests an ELC or VAC-like identity for 
the GalNac-YFP+CPB/L+ compartment. Indeed, digestion of 
ingested proteins in prelysosomal compartments has been 
described in Plasmodium parasites. Haemozoin, a visible 
byproduct of hemoglobin digestion has been observed in 
transport vesicles en route to the lysosome-like organelle of 
Plasmodium called the digestive vacuole, suggesting that 
hemoglobin digestion begins and may even be complete before 
reaching the digestive vacuole.32, 49 Where digestion begins in T. 
gondii is unclear, but rapid digestion beginning soon after 
ingestion could explain why very few parasites have detectable 
levels of ingested protein in the absence of LHVS. Future use of 
super resolution microscopy and more precise endomembrane 
markers, especially of the TGN, will better define the localization 
of ingested protein. Finally, identifying a method for monitoring T. 
gondii ingestion using live-cell imaging will also be invaluable to 
determine the order that ingested proteins travel through the 
endolysosomal compartments, the rate of endocytosis, and 
whether every parasite undergoes endocytosis.  
 
Cell Cycle Dependence of Microneme and Rhoptry 
Biogenesis 
Population-based transcriptomic studies and live cell imaging of 
fluorescently-tagged microneme and rhoptry proteins suggest 
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that microneme and rhoptry organelles are made de novo during 
daughter cell formation once per cell cycle in M/C phase.50, 51 
However, transcript levels do not necessarily correspond to 
protein levels, and fluorescent tagging of microneme and rhoptry 
proteins will label both immature protein in transit and mature 
protein within the microneme and rhoptry organelles. Our data 
suggests that microneme proproteins are present in all phases of 
the cell cycle, whereas expression of rhoptry proproteins is 
limited to S and M/C phase. It should be noted that antibodies 
used for this study may detect cleaved propeptides, which could 
persist after mature microneme and rhoptry proteins are further 
trafficked with an unknown half-life. However, the pattern of 
protein expression that we observe mirrors expression patterns 
in transcriptomic data. Microneme transcript levels undulate, but 
remain high throughout the cell cycle, whereas rhoptry protein 
transcripts show a much sharper drop in the G phase.50 Previous 
work found that expression of promicroneme and prorhoptry 
proteins is mutually exclusive such that parasites express one or 
the other, but not both.21 Together the findings imply that 
microneme biogenesis occurs in multiple waves during the cell 
cycle with a pause during a portion of S or M/C phase for rhoptry 
production. In future studies, live cell imaging of fluorescent 
protein timers, which change color over time indicating time 
since synthesis, would be informative in more accurately 
determining when microneme and rhoptry biogenesis occurs.52, 
53 
 
Cell Cycle Dependence of T. gondii Ingestion 
Endocytosis persists, but is down-regulated during the M/C 
phase of the cell cycle in mammalian cells.54-56 Similar 
observations have been made in Plasmodium parasites, which 
undergo schizogony. This process involves a G1/trophozoite 
stage followed by multiple rounds of nuclear division in S phase 
and segmentation into many parasites in M/C phase. 
Endocytosis in Plasmodium parasites begins in G1 and is 
thought to remain active until the fourth nuclear division of the S 
phase.30-33 However, examples of Plasmodium segmenters that 
appear to ingest red blood cell cytoplasm during the final stages 
of daughter cell formation have been observed.57 We find that 
ingested host cytosolic proteins can be detected in T. gondii 
parasites of all cell cycle phases. Ingestion does not appear to 
be significantly down-regulated in any phase of the cell cycle. 
However, it should be noted that we were not able to enrich for 
M/C phase parasites. Attempts to synchronize cell cycle 
progression by pulse invasion as observed by Gaji et al. 58 were 
unsuccessful, because mechanically liberated parasites used to 
infect mCherry expressing CHO cells were not homogeneously 
in G0 (data not shown). This limited our power to detect a 
decrease in ingestion in the M/C phase. 
 
Intersection of endocytosis and exocytosis in T. gondii 
Ingested protein colocalizes with proM2AP and proMIC5, but not 
proRON4. This suggests that endocytic trafficking to the VAC 
intersects with exocytic trafficking to the micronemes, which 
contrasts with the distinct phases of endocytosis and microneme 
biogenesis in Plasmodium parasites. Microneme biogenesis 
begins late in the fourth nuclear division, when endocytosis is 
shut down.30, 33 On the other hand, synthesis of Plasmodium 
rhoptry proteins has been observed as early as the 
G1/trophozoite stage.29, 59, 60 Accordingly, endocytosis and 
rhoptry synthesis likely occur at the same time, opening the 
possibility that endocytic and exocytic trafficking also intersect in 
Plasmodium. Further, the intersection of ingested protein and 
microneme protein trafficking in T. gondii implies the existence of 
sorting mechanisms that ensure ingested proteins are delivered 
to the VAC for destruction and microneme proteins remain intact 
and are delivered to the microneme organelles. We speculate 
the existence of yet unidentified receptors for sorting of cargoes 
to their target organelles, discussed further below. 
 
T. gondii ingestion of host cytosol does not require DrpB 
Expression of a dominant negative dynamin did not inhibit 
ingestion of host mCherry, suggesting that DrpB is not required 
for host mCherry endocytosis in T. gondii. However, this does 
not preclude the existence of DrpB-dependent endocytosis of 
other substrates. How host mCherry is taken up into endocytic 
vesicles in T. gondii is unclear, but could involve BAR domain 
proteins such as CtBP1/BARS, which have established roles in 
membrane fission.61 
     Interestingly, expression of ddGFP-DrpB K72A enhanced 
endocytosis and delivery of ingested protein to the VAC. While 
this could indicate the DrpB directly inhibits endocytic trafficking, 
this enhancement is likely indirect given the lack of interaction of 
the dominant negative mutant ddGFP-DrpB K72A with ingested 
mCherry or the endolysosomal system. ddGFP-DrpB K72A could 
sequester binding partners that are involved in DrpB-dependent 
exocytic trafficking along with liberating other partners. For 
example, blocking exocytic trafficking from the Golgi in 
mammalian cells leads to an increase in CLIC/GEEC 
endocytosis by freeing up the shared GTPase Arf1.62 Dynamin 
hydrolyzes GTP to GDP during membrane fission and GDP is 
exchanged for GTP to reactivate dynamin either spontaneously 
or through interaction with guanine nucleotide exchange factors 
(GEFs).63, 64 ddGFP-DrpB K72A is defective in GTP hydrolysis 
and should decrease pools of GDP-bound DrpB.12, 48 Therefore, 
ddGFP-DrpB K72A expression could lead to increased rates of 
endocytic trafficking by increasing free pools of guanine 
nucleotide exchange factors required for endocytic trafficking. 
Alternatively, both DrpB-dependent and DrpB-independent 
endocytosis could exist, and shutdown of DrpB-dependent 
endocytosis could lead to upregulation of DrpB-independent 
endocytosis. Consistent with this, knockdown of core structural 
proteins required for endocytosis via caveolae (a dynamin-
dependent endocytic pathway) leads to upregulation of the 
dynamin-independent CLIC-GEEC endocytic pathway.65 
Understanding the mechanisms that underlie T. gondii 
endocytosis should be a key focus going forward, especially 
understanding mechanisms distinguishing exocytic and 
This article is protected by copyright. All rights reserved.
endocytic trafficking.  This study provides the first glimpse into 
this aspect of T. gondii biology and suggests that DrpB is likely 
reserved for secretory trafficking only. 
 
A Model for Sorting in the T. gondii Endolysosomal System 
Taken together, we propose the following working model for 
intracellular trafficking in T. gondii (Figure 8). Because T. gondii 
replicates inside a PV, ingested proteins must traverse both the 
PV membrane (PVM) and the parasite plasma membrane. 
Studies of hemoglobin ingestion by Plasmodium, which also 
reside in a PV, showed that red blood cell cytoplasm is 
simultaneously taken up across the PVM and parasite plasma 
membrane through a mouth-like structure called the cytostome, 
producing double-membrane transport vesicles.49, 57 Vesicles 
have been seen in the cytostome-like structure of T. gondii called 
the micropore66, which is thought to be a site of endocytosis in 
the parasite, although there is no direct evidence for this. Our 
initial studies demonstrated that the intravacuolar network (IVN), 
a system of PVM-associated, membranous tubules extending 
into the PV lumen, is important for acquiring host proteins.3 
Using Plasmodium as a model, we propose that host cell 
cytoplasm is taken up into double-membrane transport vesicles 
potentially via the micropore in T. gondii. These transport 
vesicles are proposed to be the non-digestive compartment 
occupied at 7 min post-invasion and could be derived from 
endocytosis of IVN tubules or vesicles derived from the PVM. 
Active ingestion at 7 min post-invasion (Figure 2A) before the 
IVN is formed favors the existence of PVM vesicles. The IVN 
may contribute to ingestion indirectly through its role in 
organizing parasites within the PV.67, 68 We could not 
conclusively determine if ingested protein colocalized with the 
TGN, but our data is consistent with trafficking through the ELCs. 
Our model represents a conservative interpretation of the data, 
predicting yeast or mammal-like endocytic trafficking. In this 
case, transport vesicles will fuse with the ELCs, releasing PVM-
derived vesicles into the ELC lumen. The PVM-derived vesicles 
are then delivered to the VAC where they are digested. 
Intersection of ingested protein trafficking with exocytic trafficking 
to the micronemes is predicted to occur in the ELCs. How 
micronemes, rhoptries and ingested protein vesicles are further 
sorted from the ELCs to their respective target organelles is 
unclear and likely requires additional, unidentified sorting 
receptors including potential transmembrane receptors on the 
parasite surface that could escort PVM-derived vesicles to the 
VAC. Future studies will seek to better understand the molecular 
mechanisms of ingested protein trafficking to the VAC and 
sorting away from microneme proteins. Discovery of plant-like 
features will be particularly interesting and will provide potential 
targets for development of novel therapeutics that are divergent 
from the mammalian cells that T. gondii infects. 
 
MATERIALS AND METHODS 
Host Cell and Parasite Culture 
All cells and parasites were maintained in a humidified incubator 
at 37˚C with 5% CO2. CHO-K1 cells (ATCC® CCL-61™) were 
maintained in Ham’s F12 supplemented with 10% FBS, 20 mM 
HEPES, and 2 mM L-glutamine. HFF cells (ATCC® CRL-1634™) 
were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% Cosmic Calf serum, 20 mM 
HEPES, 2 mM L-glutamine, and 50µg/ml penicillin/streptomycin. 
Toxoplasma gondii parasites were maintained by serial 
passaging in HFF cells. Centrin2-EGFP parasites were kindly 
provided by Dr. Ke Hu of Indiana University and were maintained 
in the presence of 1 µM pyrimethamine.41 RH∆hx ddFKBP-GFP-
DrpB WT and RH∆hx ddFKBP-GFP-DrpB K72A parasites were 
kindly provided by Dr. Markus Meissner of University of 
Glasgow. 12 RH∆hx ddFKBP-GFP-DrpB WT parasites had lost 
transgene expression in a significant portion of the population 
and were subcloned by limiting dilution to obtain a 100% GFP+ 
population. 
 
Generation of Parasite Lines 
To generate the GalNac-YFP strain, 50µg of the pTUB GalNac 
YFP CAT plasmid69 was transfected into 1.7x107 RH parasites 
by electroporation in a 4 mm gap cuvette using a Bio-Rad Gene 
Pulser II set to exponential decay program with 1500 V, 25 µF 
capacitance and no resistance. Transfected parasites were 
cultured in HFF cells in the presence of chloramphenicol. Once 
chloramphenicol-resistant, clones were obtained by limiting 
dilution of the population and confirmed by immunofluorescence. 
 
Transient Transfection of Toxoplasma 
50µg of the pDHFR GRASP55-mRFP plasmid69 was transfected 
into 1x108 GalNac-YFP parasites by electroporation in a 4 mm 
gap cuvette in the presence of 1% DMSO using a Bio-Rad Gene 
Pulser II set to exponential decay with 2400 V, 25 µF 
capacitance and 24 Ω resistance. Transfected parasites were 
cultured in HFF cells for 24 to 48 h before experimentation. 
 
Chemicals and Reagents  
Morpholine urea-leucyl-homophenyl-vinylsulfone phenyl (LHVS) 
was kindly provided in powdered form by Dr. Matthew Bogyo at 
Stanford University. LHVS was dissolved in DMSO, and applied 
with a final DMSO concentration of 0.1-1%. Shield-1 was 
purchased from Clontech, resuspended in ethanol to a 
concentration of 1 µM and added to cultures with a final ethanol 
concentration of 0.08-0.1%. 
 
Plasmids 
pCMV mCherry N3 plasmid was kindly provided by Dr. Jonathan 
Howard Insituto Gulbenkian de Ciecia.70 pTUB-GalNac-YFP 
CAT69 and pDHFR GRASP55-mRFP35 plasmids were kindly 
provided by Dr. David Roos at University of Pennsylvania. 
pTRE2hyg plasmid (Clontech Cat# 631014) was generously 
provided by Dr. Christiane Wobus at the University of Michigan. 
 
Immunofluorescent Antibody Labeling 
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Purified parasites or chamberslides were fixed with 4% 
formaldehyde for 20 min, and washed 3 times with PBS for 5 min 
each. Slides were then permeabilized with 0.1% TritonX-100 for 
10 min, rinsed three times in PBS, blocked with 10%FBS/0.01% 
Triton X-100/PBS, and incubated in primary antibodies diluted in 
wash buffer (1% FBS/1% NGS/0.01% Triton X-100/PBS) for 1 h 
at room temperature. The following primary antibodies and 
dilutions were used in this study. Affinity purified rabbit anti-CPL 
(1:100)71, mouse anti-CPB (1:100)72, rat anti-DrpB (1:200) kindly 
provided by Dr. Peter Bradley at University of California Los 
Angeles12, affinity purified rabbit anti-proM2AP (1:400)10, guinea 
pig anti-NHE3 kindly provided by Gustavo Arrizabalaga36, rabbit 
anti-P30 (SAG1) (1:1000)73 kindly provided by Dr. John 
Boothroyd  at Stanford University, affinity purified mouse anti-
SAG1 (US Biological) (1:1000), rabbit anti-TgPI-1 (1:500)74 
affinity purified rabbit proMIC5 (1:100)13, mouse αRON4 mAb T5 
4H1 (1:100) and mouse anti-MIC3 (1:500) kindly provided by 
Jean-Francois Dubremetz42, 75, rabbit αproROP4 UVT70 
(1:3000) and mouse anti-IMC1 (1:1000) kindly provided by Dr. 
Gary Ward of University of Vermont20, 76, and rabbit anti-IMC1 
(1:1000) kindly provided by Dr. Con Beckers of University of 
North Carolina, Chapel Hill.76 Slides were washed three times 
and then incubated in Alex Fluor goat anti-mouse, anti-rabbit, 
anti-rat secondary antibody (Invitrogen Molecular Probes) diluted 
(1:1000) in wash buffer for 1 h at room temperature. Slides were 
washed three times and mounted in Mowiol before imaging. 
 
Transfection of CHO-K1 Cells 
CHO-K1 cells were plated in 35 mm dishes and transfected 
when they reached 70-80% confluency. Each dish was 
transfected with 2 µg of pCMV mCherry N3 plasmid using the X-
TREMEGENE 9 Transfection Reagent (Roche, Cat# 
6365787001) using a 3:1 ratio of plasmid to transfection reagent 
in Opti-MEM (Gibco, Cat#31985062) and a total final volume of 
200 µl. Cells were then incubated overnight at 37˚C and infected 
at 18-24 h post-transfection. 
 
Synchronized Invasion  
Synchronous invasion was accomplished using the ENDO Buffer 
Method of invasion77 with the following modifications. Briefly, 
parasite cultures were purified by scraping, syringing, and 
passing through a 3µm filter and then pelleted by spinning at 
1000xg for 10 min. The pellet was then resuspended to 1-3x107 
parasites per 1 mL in ENDO Buffer (44.7 mM K2SO4, 10mM 
MgSO4, 106mM sucrose, 5 mM glucose, 20 mM Tris–H2SO4, 3.5 
mg/ml BSA, pH 8.2) for infection of 35 mm dishes, 0.3-1x107 
parasites per 1 mL ENDO Buffer for infection of 8-well chamber 
slides. Host cells were rinsed once with ENDO Buffer, and then 1 
mL of ENDO Buffer-parasite suspension was added to each 35 
mm dish or 100µl of ENDO Buffer-parasite suspension was 
added to each chamber of an 8-well chamber slide. Parasites 
were allowed to settle at 37˚C for 10 min before the ENDO Buffer 
was removed and replaced with twice the volume of Invasion 
Media (Ham’s F12/3% Cosmic Calf Serum/20 µM HEPES). 
Parasites were allowed to invade at 37˚C for 7 or 10 min as 
indicated. Cells were washed three times with warm media to 
remove uninvaded parasites and placed back at 37˚C until ready 
for purification or fixation. 
 
Protease Protection Assay 
Protease protection assay was performed as described 
previously.3 Briefly, purified parasites were pelleted for 10 min at 
1000xg at 4˚C, supernatant was removed, and resuspended in 
250 µl of freshly prepared 1 mg/mL Pronase (Roche, Cat# 
10165921001)/0.01% Saponin/PBS and incubated at 12˚C for 1 
h. Reaction was stopped with the addition of 5 mL ice cold PBS. 
 
Intracellular Fluorescent Protein Acquisition Assay 
Transfected CHO-K1 cells were synchronously invaded by the 
ENDO Buffer method with T. gondii parasites, treated with LHVS 
or equal volume of DMSO for the indicated time prior to harvest, 
and purified at the indicated times post-invasion as previously 
described.3 For ddGFP-DrpB strains, EtOH or Shield-1 were also 
added for the indicated amounts of time prior to harvest to 
induce DrpB WT or K72A expression. All subsequent harvesting 
steps are performed on ice or at 4˚C unless otherwise noted. 
Infected cells were washed twice with ice-cold PBS to remove 
any extracellular parasites, and intracellular parasites were 
liberated and purified by scraping and syringing with a 5/8” 25g 
needle before passing through a 3 µm filter. Parasites were then 
subjected to the protease protection assay, pelleted by spinning 
at 1000xg for 10 min and washed three times in ice cold PBS 
before depositing on Cell-Tak (Corning, Cat# 354240) coated 
chamber slides. Parasites were fixed and stained with the 
indicated antibodies.  
 
Assessment of ingestion and localization 
Imaging was performed at 63x with an AxioCAM MRm camera-
equipped Zeiss Axiovert Observer Z1 inverted fluorescence 
microscope. Ingestion of host mCherry was scored manually as 
mCherry positive or mCherry negative. Colocalization of ingested 
mCherry and endolysosomal markers was scored manually with 
each individual puncta of ingested mCherry or endolysosomal 
marker signal being scored using a binary measure of 
colocalized or not. This gives a readout of percent puncta 
colocalized with a given endolysosomal marker within each 
experiment. Ingested mCherry or endolysosomal marker puncta 
were scored as colocalized if they showed any overlap, and 
there was no differentiation between complete or partial 
colocalization. An independent, blinded observer validated the 
colocalization findings for ingested mCherry by reanalyzing 15 
percent of the colocalization data. Their findings confirmed the 
reported results. 
 
Detection of MIC3 Secretion into the PV 
HFF chamber slides were synchronously invaded with ddFKBP-
GFP-DrpB WT or K72A parasites by the ENDO Buffer Method 
and treated with ethanol or Sh-1 for the indicated amounts of 
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time immediately prior to fixation at 6 h post-invasion. Chamber 
slides were fixed and stained for MIC3 and TgPI-1 as described 
above, except cells were partially permeablized with 0.02% w/v 
saponin for staining of the PV lumen but not the parasite interior. 
Cells were then blocked with 10%FBS/PBS, and incubated in 
primary and secondary antibodies diluted in wash buffer without 
detergent (1% FBS/1% NGS/PBS) to stain MIC3 as a 
representative microneme protein and the dense granule protein 
TgPI-1 as a control stain for the PV lumen. %MIC3+ vacuoles 
were determined by scoring of TgPI-1+ vacuoles for MIC3 
staining. 
 
Generating CHO-K1 inducible mCherry Cells 
A plasmid expressing mCherry under a tetracycline-inducible 
minimal CMV promoter was generated by inserting mCherry into 
the pTRE2hyg plasmid (Clontech Cat# 631014) using Gibson 
Assembly. mCherry was amplified from the pmCherry N3 
plasmid using the forward primer 5’-
ctagtcagctgacgcgtgatggtgagca agggcgag-3’ and reverse primer 
5’-tcgatgcggccgcgctagttacttgtacagctcgtc-3’. The pTRE2 plasmid 
was cut within the multiple cloning site using NheI, and mCherry 
was inserted by homologous recombination using Gibson 
Assembly Master Mix (NEB, Cat# E2611S) to generate the 
plasmid pTRE2-mCherry. Insertion was confirmed by 
sequencing. pTRE2-mCherry and pTet-On (Clontech, Cat# 
631018), expressing the reverse tet-responsive transcriptional 
activator, were cotransfected into CHO-K1 cells and selected 
with 200 µg/mL hygromycin B (Invitrogen, Cat# 10687010) and 
400 µg/mL geneticin (Invitrogen, Cat# 10131035). After recovery 
from drug selection, the cells were maintained in culture with 
200µg/mL hygromycin B and 400 µg/mL geneticin, sorted for the 
brightest mCherry signal following treatment with doxycycline 
(Clontech, Cat# 63111) by live fluorescence-associated cell 
sorting and cloned out. Clones were chosen based on screening 
for lack of signal in the absence of doxycycline and intensity of 
mCherry following treatment with addition of 1 µg/mL 
doxycycline for 48 h. Fluorescence intensity as compared to 
transiently transfected CHO-K1 WT cells was evaluated using 
flow cytometry using a BD LSRFortessa Cell Analyzer with 
FACSDiva software. 
 
Green-blue invasion assay for viability of mCherry+ 
parasites 
Ability of mCherry+ parasites to invade host cells was determined 
using a modified red-green invasion assay.78 The ntracellular 
fluorescent protein acquisition assay was performed with RH 
parasites treated with 1µM LHVS for 36 h harvested from iCHO 
imCh cells at 3 hpi with the following modifications. Protease 
protection assay was not performed, and instead, parasites were 
resuspended in 100 µl DMEM/10% Cosmic Calf serum/20 mM 
HEPES/2 mM L-glutamine/50µg/ml penicillin/streptomycin/1µM 
LHVS and allowed to invade HFF cells in an 8-chamber slide for 
30 min at 37˚C. Treatment with 1 µM LHVS during the invasion 
period was performed to prevent mCherry degradation. The 
chamber slide was then gently washed to remove uninvaded and 
unattached parasites, fixed with 4% formaldehyde for 20 min, 
and washed 3 times with PBS for 5 min each. Extracellular 
parasites were stained by blocking with 10%FBS/PBS followed 
by incubation with rabbit anti-SAG-1 diluted in wash buffer 
without detergent (1% FBS/1% NGS/PBS) for 1 h at room 
temperature. Both intracellular and extracellular parasites were 
then stained with mouse anti-SAG-1 or mouse anti-CPL 
according to the immunofluorescent antibody labeling protocol 
above beginning with Triton X-100 permeablization. 
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FIGURE LEGENDS 
FIGURE 1   Ingested host cytosolic mCherry is associated with the ELCs, VAC, and possibly the TGN. A, Experimental design for 
detection and localization of host cytosolic protein ingestion. CHO-K1 cells were transiently transfected with a plasmid encoding 
cytosolic mCherry fluorescent protein 18-24 h before synchronous invasion for 10 min with T. gondii parasites (pretreated with 1µM 
LHVS or the vehicle control DMSO for 36 h). Parasites were allowed to ingest host cytosol for 3 h in the presence of 1 µM LHVS or 
DMSO before being purified, stained and analyzed by fluorescence microscopy. B-D, Quantitation of ingestion of host cytosolic 
mCherry in WT, GalNac-YFP or ddGFP-DrpB WT parasites treated with 1 µM LHVS or DMSO. ddGFP-DrpB WT parasites were also 
treated with ethanol (EtOH) or 0.8µM Sh-1 for 30 min beginning at 2.5 h post-invasion to induce expression of DrpB WT. Shown is 
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percentage of mCherry positive parasites, at least 200 parasites analyzed per condition, ratio paired t-test for B and C, one-way 
ANOVA with Tukey’s multiple comparisons for D. E, Representative images for localization of ingested mCherry in LHVS-treated 
parasites from B-D relative to the apicoplast using DAPI staining, CPB, NHE3 or proM2AP using antibody staining, GalNac-YFP or 
GFP-DrpB WT. Scale bars: 2µm. Blue arrowhead indicates the apicoplast, and white arrows indicate areas of colocalization when the 
endolysosomal marker of interest has several puncta. F, Quantitation of colocalization of ingested mCherry with the indicated markers 
of the endolysosomal system. At least 30 ingested mCherry puncta per marker, one-way ANOVA with Dunnet’s test for multiple 
comparisons to colocalization with the apicoplast. Only significant associations shown, Apicoplast vs. NHE3 is not significant. All bars 
represent mean from 3 or more biological replicates with standard deviation error bars. * p<0.05, ** p,<0.01, ***p<0.001, ****p<0.0001, 
ns is not significant. 
 
FIGURE 2    Host cytosolic mCherry is ingested into a non-digestive compartment before delivery to the VAC within 30 min. A, Time 
course of ingestion in DMSO or LHVS-treated GalNac-YFP parasites through 1 h post-invasion. Experiment performed as in Figure 1A, 
but with a 7 min invasion period and harvested at the indicated times. Shown is percentage of mCherry positive parasites from analysis 
of at least 200 parasites analyzed per condition and time point. Ratio paired t-test comparing DMSO vs. LHVS treatment at each time 
point, * p<0.05, otherwise not significant. B, Quantitation of colocalization of ingested mCherry with CPB/L in LHVS-treated parasites 
from A stained with mouse antibodies against both CPB and CPL. At least 30 ingested mCherry puncta were analyzed per marker and 
time point. C, Representative images for localization of ingested mCherry relative CPB/L. Scale bars, 2 µm: For all graphs, points 
represent the mean of 3 biological replicates, bars represent standard deviation. 
 
FIGURE 3   Microneme proteins are expressed in G, S and M/C phase. A and B, Representative images for detection of proM2AP or 
proMIC5 by immunofluorescent staining in G, S and M/C phase Cen2-EGFP vacuoles stained for IMC1 at 4 to 6 h post-invasion. C and 
D, Quantitation of percentage of Cen2-EGFP vacuoles positive for proM2AP or proMIC5 staining in G, S and M/C phase at 4 to 6 h 
post-invasion. E and F, Representative images for detection of proM2AP or proMIC5 by immunofluorescent staining in G, S and M/C 
phase Cen2-EGFP vacuoles stained for IMC1 at 24 h post-invasion. G and H, Quantitation of percentage of Cen2-EGFP vacuoles 
positive for proM2AP or proMIC5 staining in G, S and M/C phase at 24 h post-invasion. Error bars in all graphs represent standard 
deviation, and the point where the grey fill intersects the error bars represents the mean. Values derived from 3 biological replicates 
each with at least 100 total vacuoles and at least 30 vacuoles per cell cycle phase analyzed. Scale bars: 2 µm.  
 
FIGURE 4   Rhoptry proteins are expressed in S and M/C phase. A, Representative images for detection of proROP4 by 
immunofluorescent staining in G, S and M/C phase Cen2-EGFP vacuoles at 4 to 6 h post-invasion. B, Quantitation of percentage of 
Cen2-EGFP vacuoles positive for proROP4 staining in G, S and M/C phase at 4 to 6 h post-invasion. C and D, Representative images 
for detection of proROP4 or proRON4 by immunofluorescent staining in G, S and M/C phase Cen2-EGFP vacuoles at 24 h post-
invasion. E and F, Quantitation of percentage of Cen2-EGFP vacuoles positive for proROP4 or proRON4 staining in G, S and M/C 
phase at 24 h post-invasion. Error bars in all graphs represent standard deviation, and the point where the grey fill intersects the error 
bars represents the mean. Values are derived from 3 biological replicates each with at least 100 total vacuoles and at least 30 vacuoles 
per cell cycle phase analyzed. Scale bars: 2 µm.  
 
FIGURE 5   T. gondii ingests host cytosolic mCherry throughout its cell cycle. A, Experimental design for detection and localization of 
recently ingested host cytosolic protein ingestion. CHO-K1 cells were transiently transfected with a plasmid encoding cytosolic mCherry 
fluorescent protein 18-24 h before synchronous invasion for 10 min with untreated T. gondii parasites. 50 µM LHVS or DMSO added 
during the last 30 min of infection before being purified, stained and analyzed by fluorescence microscopy. B, Quantitation of ingestion 
in Cen2-EGFP parasites treated with DMSO or LHVS for 36 h or 30 min and purified at 3 h post-invasion. Shown is percentage of 
mCherry positive parasites, at least 200 parasites analyzed per condition, One-way ANOVA with Tukey’s multiple comparisons. C, Cell 
cycle phasing of LHVS-treated Cen2-EGFP parasites harvested at 4 to 6 h post-invasion to be quantitated for ingestion in D as 
determined by pattern of Cen2-EGFP and antibody staining for IMC1. D, Quantitation of ingestion in DMSO or LHVS-treated Cen2-
EGFP parasites at 4 to 6 h post-invasion. Shown is percentage of mCherry positive parasites, at least 200 parasites analyzed per 
condition, ratio paired t-test. E, Representative images for detection of ingested host cytosolic mCherry in parasites in G, S or M/C 
phase. F, Cell cycle phase-specific analysis of ingestion pathway activity. Percentage of mCherry positive parasites in each cell cycle 
phase from parasites in D was determined with at least 230 parasites in G phase, at least 55 parasites in S phase and at least 24 
parasites in M/C phase analyzed, one way ANOVA. All bars represent the mean of 4 biological replicates, error bars represent standard 
deviation, ** p<0.01, ns = not significant, scale bars are 2 µm. 
 
FIGURE 6   Endocytic trafficking is merged with microneme biogenesis in T. gondii. A, Quantitation of mCherry ingestion in DMSO or 
LHVS-treated WT parasites at 3 h post-invasion. Experiment carried out as in Figure S5 with infection of CHO-K1 imCh cells and 200 
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µM LHVS treatment for 30 min to detect recently ingested mCherry only. Shown is percentage of mCherry positive parasites, at least 
200 parasites analyzed per condition, unpaired t-test. B, Quantitation of ingestion pathway activity during microneme biogenesis by 
comparing proMIC5 positive and negative populations. Shown is percentage of mCherry positive parasites, at least 200 parasites 
analyzed for each proMIC5 positive and negative population, ratio paired t-test. C, Quantitation of ingestion pathway activity during 
rhoptry biogenesis by comparing proRON4 positive and negative populations. Shown is percentage of mCherry positive parasites, at 
least 200 parasites for each proRON4 positive and negative population, ratio paired t-test. D, Quantitation of colocalization of ingested 
mCherry with proM2AP, proMIC5, proRON4 or the apicoplast in LHVS-treated parasites from A stained with antibodies each indicated 
marker. At least 30 ingested mCherry puncta analyzed per marker. One-way ANOVA with Dunnet’s test for multiple comparisons to 
colocalization with the apicoplast. E, Representative images of localization of ingested mCherry relative to proM2AP, proMIC5, 
proRON4 or the apicoplast (indicated by the blue arrow head). All bars represent the mean from 3 biological replicates, error bars 
represent standard deviation, ** p,<0.01, ***p<0.001, ns = not significant, scale bars are 2 µm.  
 
FIGURE 7   Ingestion does not require DrpB. A, Representative images for aberrant secretion of MIC3 into the PV lumen in ddGFP-
DrpB K72A parasites with the addition of Shield-1 (Sh-1), but not the vehicle control ethanol (EtOH). Synchronously-infected cells were 
treated with 1 µM Sh-1 or the vehicle control ethanol (EtOH) for 5 h, partially permeablized with 0.02% saponin to allow staining of the 
PV lumen, but not the parasite interior, and stained with antibodies against MIC3 and against the dense granule protein TgPI-1 as a 
positive control for PV lumen staining. Scale bars: 2 µm. B, Quantitation of aberrant MIC3 secretion into the PV lumen in ddGFP-DrpB 
K72A parasites treated as in A with 1µM Shield-1 (Sh-1) for the last 2, 3 or 5 h of infection or 5 h for ethanol (EtOH). Shown is 
percentage of TgPI-1+ vacuoles that are MIC3+, at least 100 vacuoles scored in each of 3 biological replicates. One-way ANOVA with 
Dunnet’s test for multiple comparisons to the EtOH control. C and D, Quantitation of mCherry ingestion in ddGFP-DrpB K72A and RH 
parasites. Conducted as in Figure S5A, treated with 0.2% DMSO or 200 µM LHVS for 30 min and 0.1% EtOH or 1µM Sh-1 for the 
indicated amounts of time in C and 3 h in D. Shown is percentage of mCherry positive parasites, with at least 200 parasites analyzed 
for each of 2 biological replicates for DMSO+Shield-1 in C, and at least 3 biological replicates for all other samples. One-way ANOVA 
with Dunnet’s test for multiple comparisons of LHVS+EtOH treated samples to the DMSO+EtOH treated control are not shown, but all 
comparisons are significant. Unpaired, two-sample t-tests for comparison of EtOH and Sh-1 treated samples shown. E, Quantitation of 
colocalization of ingested mCherry with GFP-DrpB K72A, proM2AP and CPL by antibody staining, or the apicoplast by DAPI staining in 
LHVS-treated ddGFP-DrpB K72A parasites from D. At least 30 ingested mCherry puncta were analyzed per marker for each of 4 
biological replicates for CPL and 3 biological replicates for all other markers. One-way ANOVA with Dunnet’s test for multiple 
comparisons of EtOH treated samples to the apicoplast are not shown, but proM2AP and CPL comparisons are significant. Unpaired 
two-sample t-tests for comparison of EtOH and Sh-1 treated samples for each marker and comparison of the apicoplast and ddGFP-
DrpB K72A in Sh-1 treated parasites shown. F, Quantitation of colocalization of CPL with the indicated markers by antibody staining in 
intracellular ddGFP-DrpB K72A parasites synchronously invaded into HFF cells, treated with 0.1% EtOH or 1µM Sh-1 for 3 h and fixed 
at 3 h post-invasion. At least 40 CPL puncta analyzed per marker for each of 3 biological replicates. Unpaired two-sample t-tests for 
comparison of EtOH and Sh-1 treated samples. G and H, Representative images for colocalization of ddGFP-DrpB WT or ddGFP-DrpB 
K72A with the indicated markers by antibody staining, quantitated in I. White arrows indicate regions of colocalization. Scale bars: 5 µm. 
I, Quantitation of colocalization of Sh-1 treated ddGFP-DrpB WT or ddGFP-DrpB K72A with the indicated endolysosomal markers by 
antibody staining or the apicoplast by DAPI staining in intracellular parasites treated as in F with ddGFP-DrpB WT parasites treated with 
0.8 µM Sh-1 for 30 min and ddGFP-DrpB K72A parasites treated with 1.0 µM Sh-1 for 3 h. At least 40 DrpB puncta analyzed per 
marker, per replicate for 3 biological replicates. One-way ANOVA with Dunnet’s test for multiple comparisons of each marker to the 
apicoplast for each ddGFP-DrpB WT and ddGFP-DrpB K72A parasites, only significant results shown. Unpaired two-sample t-tests for 
comparison of localization in ddGFP-DrpB WT vs. K72A. All bars represent means and error bars represent standard deviation. 
*p<0.05, **p<0.01, ***p<0.001, ns is not significant. 
 
FIGURE 8   Working model for trafficking and sorting of endocytic and exocytic cargoes in T. gondii. 1. Host cell cytosol (red) is taken 
up across the PVM and parasite plasma membrane into double membrane transport vesicles, potentially at the micropore. 2. These 
transport vesicles then fuse with the ELCs and deliver the host cytosol-containing, PVM-derived vesicles to the ELC lumen, where we 
propose ingested protein trafficking intersects with trafficking of microneme proteins. 3. Fusion of the ELCs with the VAC would then 
deliver the PVM-derived vesicles to the lumen of the VAC. How the PVM-derived vesicles are sorted away from the microneme proteins 
is unclear. Trafficking to the VAC may represent a bulk flow pathway independent of receptor-mediated uptake and sorting, or it could 
require unidentified receptors that recognize parasite proteins associated with the PVM-derived vesicles. This model depicts the 
possibility of receptor-mediated uptake of PVM-derived vesicles at the parasite plasma membrane and escorting them all the way to the 
VAC. 4. In the VAC, the PVM-derived vesicles are presumably ruptured by parasite lipases, releasing host cytosolic proteins and 
exposing them to degradation by parasite proteases. 5. Immature microneme and rhoptry proteins are escorted to the ELCs by 
TgSORTLR where their propeptides are cleaved off by proteases. However, trafficking at some point diverges so that trafficking of 
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microneme proteins intersect with ingested protein, but rhoptry proteins do not and may occupy a distinct subset of ELCs. 6. Microneme 
and rhoptry proteins are sorted from the ELCs to their respective organelles by unknown mechanisms that likely involve unidentified 
receptors. 
 
 
SUPPLEMENTARY FIGURE LEGENDS 
FIGURE S1   Localization of GalNac-YFP in RH GalNac-YFP parasites and viability of mCherry+ parasites. Representative images for 
localization of GalNac-YFP in RH GalNac-YFP parasites. GalNac-YFP parasites or GalNac-YFP parasites transiently transfected to 
express GRASP55-RFP were synchronously infected in HFF cells, fixed at 3 h post-invasion and stained with DAPI to label the 
apicoplast or CPB, CPL, NHE3, proM2AP and/or DrpB using antibody staining. Blue arrowhead indicates the apicoplast, and white 
arrows indicate “Golgi-free” GalNac-YFP signal. Images are representative of two biological replicates. Scale bars: 2 µm, ns is not 
significant.  
 
FIGURE S2   Localization and secretory function of ddGFP-DrpB WT. A, Representative images for lack of aberrant secretion of MIC3 
into the PV lumen in ddGFP-DrpB WT and ddGFP-DrpB K72A dominant negative mutant parasites, which have a known defect in MIC3 
trafficking resulting in secretion into the PV lumen. Synchronously-infected cells were treated with 1 µM Sh-1 or the vehicle control 
ethanol (EtOH) for 6h, partially permeablized with 0.02% saponin to allow staining of the PV lumen but not the parasite interior and 
stained with antibodies against MIC3 and against the dense granule protein TgPI-1 as a positive control for PV lumen staining. B, 
Quantitation of aberrant MIC3 secretion into the PV lumen in ddGFP-DrpB WT parasites treated with 1µM Sh-1 for the last 0.5, 1 or 6 h 
of infection or 6h with EtOH and fixed at 6 h post-invasion or ddGFP-DrpB K72A parasites treated with 1 µM Sh-1 for 6h as a positive 
control. Shown is percentage of TgPI-1+ vacuoles that are MIC3+, at least 100 vacuoles scored in each of two biological replicates. 
One-way ANOVA with Dunnet’s test for multiple comparisons to the EtOH control, only significant results shown. C, Representative 
images for localization of DrpB in RH∆hx ddFKBP-GFP-DrpB WT (top panels) and RH parasites (bottom panels). Parasites were 
synchronously invaded into HFF cells and fixed at 3 h post-invasion. ddGFP-DrpB WT parasites were treated with 0.8 µM Sh-1 for the 
last 30 min of infection, RH parasites were stained with DrpB antibodies, and both parasite strains were stained with DAPI to label the 
apicoplast or antibodies to label CPL, NHE3 or proM2AP. Blue arrowheads indicate the apicoplast. Images are representative of two 
biological replicates for RH and three biological replicates for ddGFP-DrpB parasites. All scale bars: 2 µm, bars represent means, error 
bars represent standard deviation, *p<0.05. 
 
FIGURE S3   mCherry+ parasites are viable and ingested mCherry colocalizes with GalNac-YFP in a CPB positive compartment. A, 
Harvested mCherry+ parasites are viable and can invade HFF cells. Representative images for mCherry associated with extracellular 
(EC) and intracellular (IC) parasites. Ingestion assay performed with RH parasites as described in Figure 1A using CHO imCherry cells 
(described in Figure S5) to maximize mCherry+ parasites (see Figure S5C). Following harvest, parasites were resuspended in 
DMEM/10% cosmic calf serum/20 mM HEPES/2 mM L-glutamine/50µg/ml penicillin/streptomycin treated with 1µM LHVS to inhibit 
ingested mCherry turnover during the invasion period, and a green-blue invasion assay was performed. Rabbit anti-SAG1 (blue) 
indicates EC parasites and mouse anti-SAG1 (green) will label all parasites. Images are representative of two biological replicates. B, 
Quantitation of ingestion in EC versus IC parasites depicted in A. Shown is percentage of mCherry positive parasites, at least 100 
parasites analyzed for each of two biological replicates, unpaired two-sample t-test. C, Representative images for mCherry in IC 
parasites colocalizing with CPL. Parasites treated as in A, but stained with mouse anti-CPL instead of mouse anti-SAG1. CPL 
colocalized with 77.6% (13/17) ingested mCherry puncta, suggesting the mCherry is contained within the parasites. One biological 
replicate. D, Representative images for localization of ingested mCherry relative to GalNac-YFP and CPB in LHVS-treated GalNac-YFP 
parasites stained for CPB from Figure 1. From top to bottom are examples of ingested mCherry colocalized with GalNac-YFP only, 
CPB only, both GalNac-YFP and CPB, and neither GalNac-YFP or CPB. White arrows indicate localization of ingested mCherry 
accumulation. E, Quantitation of colocalization of ingested mCherry with GalNac-YFP and/or CPB in LHVS-treated GalNac-YFP 
parasites stained for CPB from Figure 1. Data are derived from 4 biological replicates with at least 30 ingested mCherry puncta 
analyzed per marker, per replicate. F, Quantitation of colocalization of GalNac-YFP with CPB and CPL in intracellular DMSO and 
LHVS-treated parasites. HFF cells were synchronously invaded with GalNac-YFP parasites treated with DMSO or LHVS as in Figure 1, 
and fixed at 3 h post-invasion. Parasites were then stained with antibodies against CPB and CPL and analyzed by fluorescence 
microscopy. Data are derived from 2 biological replicates with at least 33 GalNac-YFP puncta analyzed per replicate. G, Representative 
images of GalNac-YFP distribution with DMSO or LHVS treatment as in C and stained for NHE3 and CPB. Scale bars, 1µM. H, 
Quantitation of colocalization of the GalNac-YFP+CPB+ compartment with other endolysosomal system markers. GalNac-YFP parasites 
were treated as in C and stained for CPB and CPL, proM2AP, NHE3, or DAPI to label the apicoplast. Data are derived from 3 biological 
replicates with at leasActiveUt 20 GalNac-YFP+CPB+ puncta analyzed per marker, per replicate, one way ANOVA with Dunnet’s test for 
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multiple comparisons to colocalization with the apicoplast, ** p,<0.01, ***p<0.001. All bars represent means, and error bars represent 
standard deviation. Scale bars: 2µm unless otherwise noted. 
 
FIGURE S4   T. gondii ingests host cytosolic mCherry within 7 min post-invasion, and peak colocalization with the GalNac-YFP+CPB/L+ 
compartment coincides with rapid degradation of ingested material. A, mCherry accumulation is contained within the SAG1 surface 
outline of the parasites at 7 min post-invasion. Experiment performed as in Figure 2, parasites were purified immediately following 
invasion (7 min post-invasion), and stained for the parasite surface marker SAG1. No protease protection assay was performed (No 
Pronase), leaving SAG1 on the surface of the parasite. Shown are cut views from Z-stacks displaying a single plane that cuts through 
the center of the accumulated mCherry signal. B, mCherry accumulation, but not SAG1 is resistant to protease protection assay 
(Pronase). Experiment performed as in A but were subjected to protease protection assay, and stained for the parasite surface marker 
SAG1. In parasites where SAG1 was digested off the parasite surface, mCherry accumulation remains. One biological replicate for A 
and B, performed in GalNac-YFP parasites treated with DMSO or 1µM LHVS for 36 h or RH∆cpl parasites as indicated. Scale bars: 
2µm. C, Quantitation of colocalization of ingested mCherry with GalNac YFP or CPB/L in LHVS-treated parasites from Figure 2. At least 
30 ingested mCherry puncta analyzed per marker and time point. Points represent the mean of 3 biological replicates, bars represent 
standard deviation. 
 
FIGURE S5   Validation of CHO-K1 imCherry cell line for detection of ingestion. A, Conceptual model for mCherry expression in CHO-
K1 inducible mCherry (CHO-K1 imCh) cell. CHO-K1 cells that stably express mCherry under the control of the minimal CMV promoter 
and the tetracycline-responsive element (TRE) as well as the reverse tetracycline-controlled transactivator (rtTA) were generated. In the 
absence of tetracycline or its derivative doxycycline, rtTA cannot bind the TRE, and cytosolic mCherry transcription is repressed. In the 
presence of doxycycline, doxycycline will bind to rtTA and allow it to bind to the TRE and induce transcription of cytosolic mCherry. B, 
From top to bottom, representative images of mCherry detection in the parental CHO-K1 WT cell line, CHO-K1 WT cells transiently 
transfected with the pmCherry N3 plasmid, CHO-K1 imCh cells without DOX for 96 h and CHO-K1 imCh cells treated with 2µg/mL DOX 
for 96 h. To the right are values for the percentage of cells that are mCherry positive (%mCh+) and mean fluorescence intensity of the 
mCherry (MFI) as determined by flow cytometry. Data derived from 2 biological replicates with 20,000 cells analyzed per condition per 
replicate. Scale bar, 20µm. C, Quantitation of ingestion of host cytosolic mCherry from CHO-K1 WT, CHO-K1 WT cells transiently 
transfected to express cytosolic mCherry, CHO-K1 imCh cells without DOX for 96 h and CHO K1-imCh cells with 2µg/mL DOX for 96 h. 
Cells were synchronously invaded for 10 min with WT parasites treated with DMSO or LHVS as indicated, purified at 3 h post-invasion, 
fixed and analyzed by fluorescence microscopy. Shown is percentage of mCherry positive parasites with at least 200 parasites 
analyzed per condition, one way ANOVA with Tukey’s test for multiple comparisons, ** p<0.01, ***p<0.001, ns = not significant. D, 
Representative images of detection of ingested mCherry from parasites in C. Scale bars: 5µm. 
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Decision and Reviews   
 
Dear Dr. Carruthers, dear Vern,  
 
Thank you for submitting your manuscript “Intersection of endocytic and exocytic systems in Toxoplasma gondii” for 
consideration for publication in Traffic.  I asked two colleagues who are experts in the field to review the paper and 
their verbatim comments are appended below.  I share the view of the referees that the work presented in this paper 
is of a high technical caliber and will be of interest.  However, I also agree with both referees that some mechanistic 
insight (functional interference of endocytosis) would significantly increase the impact of this study.  The referees 
have made excellent suggestions for the experiments to include.  
 
Although I cannot accept your manuscript for publication at this point, I believe that you will be able to address the 
referees’ concerns and I look forward to receiving your revised manuscript. To expedite handling when you resubmit 
please be sure to include a response outlining how you have addressed each of the referees’ concerns.  
 
Sincerely,  
 
Dominique Soldati-Favre, Ph.D.  
Associate Editor  
________________________________________________________  
Referee's Comments to the Authors  
 
Referee: 1  
 
Comments to the Author  
Review of McGovern et al.,  
Summary:  
In this study the authors investigate the trafficking of ingested host cell proteins by the apicomplexan parasite 
Toxoplasma gondii. Previous studies by the Carruther’s group demonstrated the intracellular parasites are capable to 
take up host proteins that are trafficked to a lysosome like compartment, the VAC. However, to date it is unknown, 
how this protein uptake occurs, which routes are taken and which trafficking factors are used.  
In this study the Carruther’s group demonstrate that endocytic and exocytic pathways intersect and that the host 
proteins are delivered to the VAC using a (probably) conserved transport pathway.  
Furthermore, the authors present evidences that de novo synthesis and transport of micronemal proteins occur 
throughout the cell cycle, while rhoptry proteins appear to be synthesised only during S and M/C phase.  
Together this study provides important novel insights about the general organisation of endocytic and exocytic 
transport pathways in Toxoplasma gondii  
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Own opinion:  
The authors use a nice and reliable assay in order to detect and follow the uptake of a reporter protein (mCherry), 
expressed in the host cell, into the parasite. Previously the authors demonstrated uptake and delivery of the proteins 
into the VAC, indicating involvement of a “conserved” trafficking machinery, similar to other eukaryotes.  
In general, the performed analysis is well conducted and the conclusions appear valid. I think the study is of general 
interest and can be published after (minor) revision.  
 
Major criticism:  
1.) The study is observational and could be substantially improved by providing some mechanism, to determine if 
ingestions uses (as proposed) conserved factors. This could be achieved by using some mutants for the discussed 
endocytic factors (Clathrin, Dynamin, etc.). Alternatively, inhibitors such as Pitstop, Phenylarsine or Cytochalasin D 
could be used to assess if uptake is clathrin or actin dependent.  
 
2.) The whole experimental approach is based on end point assays followed by colocalisation analysis. Although 
properly done with all necessary controls provided, it would be great if the authors could provide more dynamic 
insights using time lapse imaging.  
 
3.) The necessity to scratch syringe the parasite prior to image analysis is introducing some uncertainty. Did the 
authors test if parasites positive for mCherry are viable and can re-invade?  
 
4.) The authors provide data concerning de novo synthesis of microneme and rhoptry proteins and reach the 
conclusion that micronemes are synthesised throughout the cell cycle, whereas rhoptries are only synthesised during 
S and M/C phase. These results are in conflict to Besterio et al, 2009 (see Figure 4). In this study the authors 
concluded that synthesis of micronemes and rhoptries is tightly regulated and asynchronous. Importantly, co-staining 
with proM2AP/proRon4 or proRon8/proMIC3 demonstrated the presence of PVs with parasites either positive for the 
rhoptry OR the microneme marker, indicating tight regulation of both. It might be a choice of markers and/or 
antibodies that leads to these differences. It is suggested to repeat the experiment to solve this issue, since it is a 
major point of the study.  
 
Minor criticism:  
1.) The model in Figure 5 assumes uptake via the micropore. The authors demonstrated in a previous report that the 
presence of the intravacuolar network is critical for uptake, suggesting that proteins enter the parasite via this 
network. The authors should discuss this in more detail. At this point it is still unclear how the host proteins enter the 
parasite.  
 
2.) The discussion could be significantly shortened and more focused on the presented results.  
 
Referee: 2  
 
Comments to the Author  
This manuscript provides a careful quantitative imaging-based analysis of the interaction between the newly 
described endocytic pathway and the better studied exocytic pathway in Toxoplasma. The data generally appears 
high quality, largely reproducible (although with large error bars in some cases) and is carefully controlled. The data 
concludes, from a battery of co-localisation experiments, that micronemal proteins and the endocytic pathway 
intersect, but that rhoptry proteins take a different route and are more tightly cell-cycle regulated.  
 
Overall, I find this work solid and important to report (provided the comments below), however, this manuscript has 
nothing in the way of functional work to back up the claims of this proposed pathway. This is eminently achievable 
given available genetic tools and prior knowledge in Rab biology and characterization of molecular players in the Toxo 
secretory pathway. Any molecular understanding of this pathway would be very welcome and make much more 
compelling study.  
 
The only major technical point that needs clarification is whether deconvolution was used throughout the study, 
before co-localisation was scored. This would be essential to discount co-localisation based on detection of out-of-
focus light. I cannot find any evidence in the material and methods section. There is only explicit use of deconvolution 
in Fig S3 and associated text, making me wonder whether it was used throughout or just there?  
 
Minor points:  
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In the first results section ‘Characterisation of parasites stably expressing GalNAc-YFP’ – no figure is referenced. I 
assume the authors should have referred to Figure S1 and S2?  
 
It seems an important observation that GalNac-YFP does probably not exclusively mark the Golgi to to its co-
localisation with CPL/B and mCherry. Would it be worth confirming this using the GRASP55 FP fusion?  
 
I find it a little puzzling as to why only 5-15% of parasites (with and without LHVS) have undergone mCherry ingestion. 
I would have expected higher levels, over the longer periods of time assessed.  
_____________________________________________________________________________
Author Rebuttal  
 
Referee: 1  
Comments to the Author  
Review of McGovern et al.,  
Summary:  
In this study the authors investigate the trafficking of ingested host cell proteins by the apicomplexan parasite 
Toxoplasma gondii. Previous studies by the Carruther’s group demonstrated the intracellular parasites are capable to 
take up host proteins that are trafficked to a lysosome like compartment, the VAC. However, to date it is unknown, 
how this protein uptake occurs, which routes are taken and which trafficking factors are used.  
In this study the Carruther’s group demonstrate that endocytic and exocytic pathways intersect and that the host 
proteins are delivered to the VAC using a (probably) conserved transport pathway.  
Furthermore, the authors present evidences that de novo synthesis and transport of micronemal proteins occur 
throughout the cell cycle, while rhoptry proteins appear to be synthesised only during S and M/C phase.  
Together this study provides important novel insights about the general organisation of endocytic and exocytic 
transport pathways in Toxoplasma gondii  
 
Own opinion:  
The authors use a nice and reliable assay in order to detect and follow the uptake of a reporter protein (mCherry), 
expressed in the host cell, into the parasite. Previously the authors demonstrated uptake and delivery of the proteins 
into the VAC, indicating involvement of a “conserved” trafficking machinery, similar to other eukaryotes.  
In general, the performed analysis is well conducted and the conclusions appear valid. I think the study is of general 
interest and can be published after (minor) revision.  
 
Major criticism:  
1.) The study is observational and could be substantially improved by providing some mechanism, to determine if 
ingestions uses (as proposed) conserved factors. This could be achieved by using some mutants for the discussed 
endocytic factors (Clathrin, Dynamin, etc.). Alternatively, inhibitors such as Pitstop, Phenylarsine or Cytochalasin D 
could be used to assess if uptake is clathrin or actin dependent.  
 
Response  
This is a valid and important consideration for the study that we were aware of prior to submitting the manuscript. 
Accordingly, we had already started to test the role of Dynamin-related protein B (DrpB) in trafficking of ingested 
material using a regulatable dominant negative mutant of DrpB (ddGFP –DrpB 72A) that was previously shown to 
impact the trafficking of proteins to the micronemes and rhoptries. Although using a DN mutant is not without it own 
limitations, we felt this approach was better than using inhibitors that have not been validated in T. gondii and/or 
that will also have potentially confounding effects on host cells. We also carefully assessed the time-dependent 
effects of the DN mutant and measured impact at the shortest effective induction times to minimize secondary 
effects.  
 
Interestingly, as shown in a new 9-panel figure (Figure 7), we found that interfering with DrpB function increased 
ingestion of host-derived protein into the parasite. The findings imply not only that ingestion does not require DrpB, 
but also that DrpB might restrict ingestion or that crosstalk between DrpB-dependent and DrpB-independent 
pathways exists. Possible explanations for these findings are also considered in the revised discussion.  
 
Experiments are planned to test the roles of additional trafficking determinants (clathrin, rabs, adaptor proteins, etc) 
using the auxin-inducible degradation system, but it will take some time to optimize the system. We envision that 
such studies will be part of the next “chapter” in this line of investigation.  
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2.) The whole experimental approach is based on end point assays followed by colocalisation analysis. Although 
properly done with all necessary controls provided, it would be great if the authors could provide more dynamic 
insights using time-lapse imaging.  
 
Response  
We agree that it would be ideal to visualize ingestion via time-lapse imaging in live, infected cells. However, bright 
signal from the cytosol of transfected host cells obscures signal within the parasite when visualized by wide field 
microscopy. We attempted several strategies to obviate this. First, we tried line-scanning confocal microscopy to limit 
interference from out of focus signal from the host cell cytosol. Second, we used dye called pHrodo-AM, which 
increases in fluorescence intensity at low pH, to label the host cytosol instead of mCherry. We expected that 
endocytic delivery of pHrodo to the VAC should result in increased fluorescence intensity due to the acidic 
environment, thus allowing visualization of ingested material. Unfortunately, neither of these approaches worked 
sufficiently well to reliably visualize ingestion in live infected cells. We also tried expressing in the host cytosol a 
photoactivatable form of mCherry (PA-mCh) fused the RAH domain of TgROP5, which directs association with the 
PVM. This approach significantly reduced signal from the host cell by selectively photoactivating PA-mCh proximal to 
the PVM. We were able to visualize what appeared to be vesicular trafficking within the PV, but we were unable to 
track it into the parasite. We also failed to detect accumulation of TgROP5 RAH domain fused to YFP in the parasite 
using our traditional ingestion assay, implying that ingestion of this protein is below the limit of detection. We are 
currently testing a protease-activated mCherry, but have thus far not seen evidence of this working. We will continue 
to invest in strategies for live imaging, but a solution for this is not available presently.  
 
 
3.) The necessity to scratch syringe the parasite prior to image analysis is introducing some uncertainty. Did the 
authors test if parasites positive for mCherry are viable and can re-invade?  
 
Response  
 
This is an important point that we tested by recovering LHVS treated parasites from inducible mCherry CHO host cells 
according to our normal harvest procedure, and inoculated them into fresh HFF cells. We found that mCherry+ 
parasites were capable of binding to HFF cells and a similar proportion were able to successfully invade host cells 
(FigureS3A-C), suggesting that mCherry+ positive parasites are viable. That this proportion is somewhat lower than 
the ~42% of total parasites that were mCherry+ (based on FigureS5C) is probably due to the known effect of LHVS 
treatment on microneme secretion, which is required for parasite attachment and invasion (Teo et al, Antimicrob 
Agents Chemother 2007). The ability of mCherry+ parasites to reinvade host cells is now mentioned in the first 
paragraph of the section titled “Ingested proteins traverse ELCs but likely not the TGN”.  
 
 
4.) The authors provide data concerning de novo synthesis of microneme and rhoptry proteins and reach the 
conclusion that micronemes are synthesized throughout the cell cycle, whereas rhoptries are only synthesized during 
S and M/C phase. These results are in conflict to Besterio et al, 2009 (see Figure 4). In this study the authors 
concluded that synthesis of micronemes and rhoptries is tightly regulated and asynchronous. Importantly, co-staining 
with proM2AP/proRon4 or proRon8/proMIC3 demonstrated the presence of PVs with parasites either positive for the 
rhoptry OR the microneme marker, indicating tight regulation of both. It might be a choice of markers and/or 
antibodies that leads to these differences. It is suggested to repeat the experiment to solve this issue, since it is a 
major point of the study.  
 
Response  
Although we can understand why the reviewer suggests a conflict between the data in our study versus that of 
Besteiro et al 2009, our study did not directly test the synchronicity of microneme versus rhoptry synthesis, and the 
Besteiro study did not assess microneme and rhoptry biogenesis with markers of the cell cycle. Three different 
individuals in our lab independently obtained similar results for analysis of cell cycle dependent expression of proMICs 
and proROPs, and, knowing Dr. Besteiro, it can be expected that his analysis was equally thorough. Also, we have 
previously validated the specificity of the affinity purified anti-proM2AP antibody on ∆m2ap mutant parasites. Since 
we used a new batch of anti-proMIC5 for the current study, we also authenticated its specificity on ∆mic5 parasites. 
To explain the respective findings, we suggest in the discussion that microneme biogenesis could occur in multiple 
waves during the cell cycle with a pause during a portion of S or M/C phase for rhoptry production. See discussion 
section “Cell Cycle Dependence of Microneme and Rhoptry Biogenesis”.  
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Minor criticism:  
1.) The model in Figure 5 assumes uptake via the micropore. The authors demonstrated in a previous report that the 
presence of the intravacuolar network is critical for uptake, suggesting that proteins enter the parasite via this 
network. The authors should discuss this in more detail. At this point it is still unclear how the host proteins enter the 
parasite.  
 
Response  
These are both excellent points. Although the micropore is our best guess for the site of endocytosis in T. gondii, 
there is no direct evidence for this. Accordingly, we removed the micropore from the illustrated model in Figure 8. We 
also modified the discussion to indicate that the micropore is a likely, but not definitive site of endocytosis, based on 
the Plasmodium paradigm.  
 
Discussion of the role of the IVN has also been added. As now indicated in the manuscript, Dou et al. (mBio 2014) 
found that ingestion was reduced in GRA2 knockout parasites, which do not have IVN tubules. This was interpreted to 
mean that the IVN was required for ingestion, and may contribute as a direct conduit for uptake of host cytosol. 
Within our model, this would mean endocytosis of IVN tubules into the parasite. However the experiment in Dou et al 
was performed at 24 h post-infection when GRA2 knockout leads to the loss of IVN tubules and disorganization of 
parasites within the PV. Our result in Figure 2 that ingestion is active at 7 min post-invasion when IVN tubules have 
not yet formed, suggests that the IVN is not required for acquisition of host cytosol, at least at this early time point. 
We have confirmed this by comparing ingestion in WT versus GRA2 knockout parasites at early time points before 
disorganization occurs (7 min to 3 h post-invasion), and found no significant differences. This data is not included in 
this paper, and will be part of the next “chapter” of our ongoing studies exploring the mechanisms of ingested protein 
trafficking across the PVM. With these findings, it remains possible that the IVN contributes to ingestion at later time 
points, or that the IVN is not directly involved in ingestion but instead affects ingestion indirectly via its role in 
organizing the parasites within the PV.  
 
 
2.) The discussion could be significantly shortened and more focused on the presented results.  
 
Response  
We have shorted the discussion by ~22% along with placing greater emphasis on the presented results.  
 
 
Additional changes to the revised manuscript:  
Efforts were made to condense all sections of the manuscript. We also assessed the localization of ddGFP-DrpB WT 
within the T. gondii endolysosomal system (FigureS2) and colocalization of ingested host mCherry with ddGFP-DrpB 
DrpB (Figure 1) to compliment the data in Figure 7 addressing the role of DrpB in T. gondii endocytosis. Figures S3 and 
S4 were combined to accommodate a new Figure S2.  
 
 
Referee: 2  
Comments to the Author  
This manuscript provides a careful quantitative imaging-based analysis of the interaction between the newly 
described endocytic pathway and the better studied exocytic pathway in Toxoplasma. The data generally appears 
high quality, largely reproducible (although with large error bars in some cases) and is carefully controlled. The data 
concludes, from a battery of co-localisation experiments, that micronemal proteins and the endocytic pathway 
intersect, but that rhoptry proteins take a different route and are more tightly cell-cycle regulated.  
 
1.) Overall, I find this work solid and important to report (provided the comments below), however, this manuscript 
has nothing in the way of functional work to back up the claims of this proposed pathway. This is eminently 
achievable given available genetic tools and prior knowledge in Rab biology and characterization of molecular players 
in the Toxo secretory pathway. Any molecular understanding of this pathway would be very welcome and make much 
more compelling study.  
 
Response  
Since this a similar comment was provided by R1, we reiterate the response as follows:  
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This is a valid and important consideration for the study that we were aware of prior to submitting the manuscript. 
Accordingly, we had already started to test the role of Dynamin-related protein B (DrpB) in trafficking of ingested 
material using a regulatable dominant negative mutant of DrpB (ddGFP –DrpB 72A) that was previously shown to 
impact the trafficking of proteins to the micronemes and rhoptries. Although using a DN mutant is not without it own 
limitations, we felt this approach was better than using inhibitors that have not been validated in T. gondii and/or 
that will also have potentially confounding effects on host cells. We also carefully assessed the time-dependent 
effects of the DN mutant and measured impact at the shortest effective induction times to minimize secondary 
effects.  
 
Interestingly, as shown in a new 9-panel figure (Figure 7), we found that interfering with DrpB function increased 
ingestion of host-derived protein into the parasite. The findings imply not only that ingestion does not require DrpB, 
but also that DrpB might restrict ingestion or that crosstalk between DrpB-dependent and DrpB-independent 
pathways exists. Possible explanations for these findings are also considered in the revised discussion.  
 
Experiments are planned to test the roles of additional trafficking determinants (clathrin, rabs, adaptor proteins, etc) 
using the auxin-inducible degradation system, but it will take some time to optimize the system. We envision that 
such studies will be part of the next “chapter” in this line of investigation.  
 
2.) The only major technical point that needs clarification is whether deconvolution was used throughout the study, 
before co-localisation was scored. This would be essential to discount co-localisation based on detection of out-of-
focus light. I cannot find any evidence in the material and methods section. There is only explicit use of deconvolution 
in FigureS3 and associated text, making me wonder whether it was used throughout or just there?  
 
Response  
Deconvolution was used for FigureS4, but it was not used for colocalization studies because we do not have access to 
a fast deconvolution instrument capable of rapidly capturing the Z-stacks needed for accurate deconvolution on large 
enough image sets to obtain robust quantitative data. We understand that wide field microscopy has limitations; 
however, it should be noted that ingested material did not substantially colocalize with all discrete apical markers 
including the apicoplast or NHE3, providing a measure of validity to the more obvious colocalization seen with 
proM2AP, CPB, and DrpB (Figure1). We expect that our future work will take advantage of major instrumentation 
upgrades that are pending at our host institution to achieve greater resolution and thus more precise localization 
analysis.  
 
Minor points:  
 
1.) In the first results section ‘Characterization of parasites stably expressing GalNAc-YFP’ – no figure is referenced. I 
assume the authors should have referred to Figure S1 and S2?  
 
Response  
Reference to FigureS1 was inserted into this section.  
 
2.) It seems an important observation that GalNac-YFP does probably not exclusively mark the Golgi to its co-
localisation with CPL/B and mCherry. Would it be worth confirming this using the GRASP55 FP fusion?  
 
Response  
Thank you for this suggestion. Please see FigureS1 where images comparing GalNac-YFP and GRASP55-RFP are 
included. In the bottom panel, a new image, which has clearer GRASP55-free signal, has been substituted and white 
arrowheads indicate the Golgi-free bodies. Please find a description of the colocalization of GalNac-YFP and GRAS55-
RFP including a more explicit statement about GalNac-YFP not being restricted to the TGN included in the text results 
section now titled “Localization of TGN/ELC markers: GalNac and DrpB” and summarized below:  
 
“Consistent with TGN localization, GalNac-YFP appeared in a centrally located structure that overlapped substantially 
with, or was just apical to, the Golgi marker GRASP55-mRFP (Figure S1). As previously observed, GalNac-YFP 
sometimes showed a high degree of overlap with another TGN marker the dynamin-related protein DrpB (Figure S1A 
top panel), but in other cases showed partial or no overlap with DrpB (Figure S1A bottom panel). Interestingly, 
GalNac-YFP overlapped best with NHE3 in the central region of the parasite despite previous observations that NHE3 
partially colocalized with the VAC.36 Therefore, we interpret NHE3 to be an ELC marker that partially overlaps with 
the TGN, similar to the established ELC marker proM2AP.10,37 GalNac-YFP also partially overlapped with proM2AP, 
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but rarely colocalized with the VAC markers CPB and CPL or the apicoplast. We also observed that some parasites had 
GalNac-YFP-labeled structures that were not associated with GRASP55-mRFP (Figure S1, white arrowheads). These 
structures are reminiscent of “Golgi-free” TGN bodies in plants38 This observation together with substantial overlap 
with the ELC marker proM2AP, suggests GalNac-YFP occupies the TGN, ELCs, and perhaps additional sites.”  
 
3.) I find it a little puzzling as to why only 5-15% of parasites (with and without LHVS) have undergone mCherry 
ingestion. I would have expected higher levels, over the longer periods of time assessed.  
 
Response  
Thank you for the opportunity to explain the apparent low percentage of mCherry+ parasites. LHVS treated parasites 
recovered from transiently transfected CHO host cells are 10-15% mCherry+. Since only 20% of transiently transfected 
host cells are mCherry+ (FigureS5B), this means that 50-75% of the parasites exposed to mCherry have ingested 
mCherry. LHVS treated parasites recovered from inducible mCherry CHO cells are ~42% mCherry positive (FigureS5C). 
Because approximately 76% of inducible mCherry CHO cells are mCherry+, this indicates that roughly 55% of the 
parasites exposed to mCherry have ingested this reporter. Together this suggests that most parasites are actively 
endocytosing material from the host cytosol. It is possible that this is an underestimate for several reasons: (1) some 
of the transiently transfected mCherry+ host cells are dimmer than others; hence ingestion from these cells might not 
reach the threshold of detection within the parasite by microscopy; (2) although more uniform in expression, the 
inducible mCherry CHO cells are generally dimmer than the brightest transiently transfected cells (FigureS5), thus less 
active parasites might not accumulate sufficient mCherry for detection; (3) LHVS treatment inactivates CPL and 
probably CPB, but does not inactivate other yet-to-be-identified VAC proteases that are responsible for residual 
proteolytic activity in the VAC (Dou et al., mBio 2014). Accordingly ingested mCherry is still being turned over to some 
extent in LHVS treated parasites, further limiting detection in some parasites; and (4) although mCherry is more pH 
tolerant than e.g., GFP, the low pH of the VAC could compromise the signal in less parasites that are less trophic. To 
summarize, we do not know precisely what proportion of the parasites are actively endocytosing material from the 
host cytosol, but the available evidence suggests it is at least half of the population.  
 
 
Additional changes to the revised manuscript:  
Efforts were made to condense all sections of the manuscript. We also assessed the localization of ddGFP-DrpB WT 
within the T. gondii endolysosomal system (FigureS2) and colocalization of ingested host mCherry with ddGFP-DrpB 
DrpB (Figure 1) to compliment the data in Figure 7 addressing the role of DrpB in T. gondii endocytosis. Figures S3 and 
S4 were combined to accommodate a new Figure S2. 
_____________________________________________________________________________ 
Decision and Reviews   
 
Dear Dr. Carruthers, dear Vern,  
 
Thank you for submitting your revised manuscript "Intersection of endocytic and exocytic systems in Toxoplasma 
gondii" to Traffic.  I asked the referees to read the paper and their verbatim comments are appended below.  I agree 
with the referees that you have adequately addressed the concerns raised previously and I am pleased to accept this 
paper for publication.  
 
Sincerely,  
 
Dominique Soldati-Favre, PhD  
Associate Editor  
________________________________________________________  
Referee's Comments to the Authors  
 
Referee: 2  
 
Comments to the Author  
I still find it a little disappointing that the authors have only included, what can only really be considered a negative 
result, as functional data. It can only be concluded here that DrpB is not involved directly in endocytosis. The authors 
say that more functional data is now being generated, but this will of course take much longer to analyse.  
 
All other queries have been sufficiently addressed.  
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Referee: 1  
 
Comments to the Author  
In their revision, McGovern et al. addressed all my initial concerns. While the results regarding DrpB are not 
demonstrating a potential mechanisms for endocytic uptake and are somewhat confusing, the authors discuss these 
findings appropriately. It is out of the scope of this study to characterise additional, potential trafficking factors 
involved in endocytosis. As it stands, this would likely result in a huge fishing approach and would not be feasible 
within a realistic revision time.  
Meanwhile, this study clearly demonstrates uptake via a "partially" conserved endocytic/exocytic transport system in 
Toxoplasma gondii and will be of general interest to the field.  
I congratulate the authors to a nice and well performed study.  
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